• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register

SU-9516

Product ID S800000
Cas No. 377090-84-1
Purity ≥98%
Product Unit SizeCostQuantityStock
5 mg $121.10 In stock
25 mg $364.70 In stock
100 mg $927.00 In stock
Bulk Quote
Add to Wishlist

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

SU-9516 is an inhibitor of cyclin-dependent kinase (CDK), with selectivity for CDK2. It induces apoptosis in colon carcinoma cells. In leukemic cells, it downregulates Mcl-1, an antiapoptotic protein, leading to mitochondrial injury and cell death.

Product Info

Cas No.

377090-84-1

Purity

≥98%

Formula

C13H11N3O2

Formula Wt.

241.25

IUPAC Name

(3Z)-3-(1H-Imidazol-4-ylmethylene)-5-methoxy-1,3-dihydro-2H-indol-2-one

Synonym

SU9516

Shipping and Storage

Store Temp

4°C

Ship Temp

Ambient

Downloads

MSDS

S800000 MSDS PDF

Info Sheet

S800000 Info Sheet PDF

References

Opyrchal M., Salisbury J., et al. Inhibition of Cdk2 kinase activity selectively targets the CD44⁺/CD24⁻/Low stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells. Int J Oncol. 45(3):1193-9 (2014). PMID:24970653.

Lane M., Yu B., et al. A novel cdk2-selective inhibitor, SU9516, induces apoptosis in colon carcinoma cells. Cancer Res. 61(16):6170-7 (2001). PMID: 11507069.

Gao N., Kramer L., et al. The three-substituted indolinone cyclin-dependent kinase 2 inhibitor 3-[1-(3H-imidazol-4-yl)-meth-(Z)-ylidene]-5-methoxy-1,3-dihydro-indol-2-one (SU9516) kills human leukemia cells via down-regulation of Mcl-1 through a transcriptional mechanism. Mol Pharmacol. 70(2):645-55 (2006). PMID: 16672643.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2023 LKT Laboratories, All Rights Reserved - Products for research use only